Silo Wellness Secures Right of First Refusal on All Psilocybin Mushroom Biomass from Medford, Oregon First-Mover Satya; Other Corporate Updates
Ryan Allway March 24th, 2023 News, Top News Springfield, Oregon–(Newsfile Corp. – March 24, 2023) – Silo Wellness Inc. (CSE: SILO) (OTCQB: SILFF) (FSE: 3K7A), announces that it is partnering with Oregon-based Satya, Inc. to develop a robust ecosystem aimed at supporting the well-being of psilocybin patients and Oregonian entrepreneurs alike.... Read more
Cybin Receives FDA IND Clearance for its Phase 1/2a Clinical Trial Evaluating CYB003 for the Potential Treatment of Major Depressive Disorder
Ryan Allway June 27th, 2022 Psychedelics, Top News — Marks the first novel psilocybin analog to enter clinical development —— Patient recruitment to commence immediately —— Pharmacokinetic and safety data readout expected in Q4 2022 — TORONTO, June 27, 2022–(BUSINESS WIRE)–Cybin Inc. (NEO:CYBN) (NYSE American:CYBN) (Cybin or the Company), a biopharmaceutical company... Read more
TRYP Therapeutics Announces results of First Patient Dosed in its Phase II Clinical Trial for the Treatment of Binge Eating Disorder
Initial data readout supports the potential effectiveness of psilocybin and psilocybin-related compounds for the treatment of Binge Eating Disorder San Diego, California — (June 9, 2022) – Tryp Therapeutics, Inc. (CSE: TRYP) (OTCQB: TRYPF) (“Tryp” or the “Company”), a clinical-stage biotechnology company focused on developing psilocybin-based compounds for diseases with unmet... Read more
SciSparc’s Ordinary Shares to Commence Trading on Nasdaq Capital Market Today
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any... Read more
Levitee Labs Announces Strategic Partnership with LiveRx Research Group to Provide Equitable Access to Hepatitis C Care throughout Alberta, Canada
Ryan Allway December 20th, 2021 Treatment for Hepatitis C Virus (HCV) is effective in over 95% of infected patients, yet remains disproportionately unavailable to certain patient groups across Canada. Levitee Clinics and Levitee Pharmacies will work collaboratively with LiveRx to create easily accessible patient-centric HCV care, impacting currently under-served... Read more
Cannabis May Reduce Alcohol Consumption

There was an interesting study about cannabis and alcohol consumption recently conducted by a team out of the University of Colorado at Boulder. In their findings, they concluded that cannabis consumption may decrease alcohol intake by individuals being treated for alcohol abuse. The relationship between alcohol use in conjunction with cannabis is one that has […]

The post Cannabis May Reduce Alcohol Consumption appeared first on The Cannifornian.

Read more
6 Reasons Dog Owners Are Turning to CBD

Humans have used cannabis for over a thousand years to treat various illnesses. Now, many pet owners are turning to cannabis products to treat their sick pets as well and finding it very beneficial.

The post 6 Reasons Dog Owners Are Turning to CBD appeared first on The Cannifornian.

Read more
Micron Waste Secures US Biotech Patent
Company Strengthens IP Protection for Food and Cannabis Waste Processing Systems Market leadership – US patent recognizes and protects Micron’s biotechnology effluent treatment process to purify wastewater for government-compliant discharge or re-use Platform validation – Micron’s microbial and enzymatic waste digestion formulation has been validated in food and cannabis,... Read more
( ) ( ) ( ) ( ) ( ) ( ) ( ) ( )